166 related articles for article (PubMed ID: 31028894)
1. Global Initiative for Asthma 2016-derived asthma control with fluticasone propionate and salmeterol: A Gaining Optimal Asthma Control (GOAL) study reanalysis.
Bateman ED; Busse W; Pedersen SE; Bousquet J; Huang S; Zhou X; Gul N; Hollis S; Gibbs M
Ann Allergy Asthma Immunol; 2019 Jul; 123(1):57-63.e2. PubMed ID: 31028894
[TBL] [Abstract][Full Text] [Related]
2. Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study.
Bousquet J; Barnes N; Gibbs M; Gul N; Tomkins SA; Zhou X; Cho YJ; Park HS; Busse W; Zhong N
BMC Pulm Med; 2017 Apr; 17(1):75. PubMed ID: 28454528
[TBL] [Abstract][Full Text] [Related]
3. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma.
Mendes ES; Rebolledo P; Wanner A
Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058
[TBL] [Abstract][Full Text] [Related]
5. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[TBL] [Abstract][Full Text] [Related]
6. Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.
Murray J; Rosenthal R; Somerville L; Blake K; House K; Baitinger L; VanderMeer A; Dorinsky P
Ann Allergy Asthma Immunol; 2004 Oct; 93(4):351-9. PubMed ID: 15521371
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol/fluticasone propionate versus fluticasone propionate plus montelukast: a cost-effective comparison for asthma.
Pieters WR; Wilson KK; Smith HC; Tamminga JJ; Sondhi S
Treat Respir Med; 2005; 4(2):129-38. PubMed ID: 15813665
[TBL] [Abstract][Full Text] [Related]
8. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[TBL] [Abstract][Full Text] [Related]
9. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.
Bateman ED; Boushey HA; Bousquet J; Busse WW; Clark TJ; Pauwels RA; Pedersen SE;
Am J Respir Crit Care Med; 2004 Oct; 170(8):836-44. PubMed ID: 15256389
[TBL] [Abstract][Full Text] [Related]
10. Inhaled salmeterol/fluticasone propionate combination. A pharmacoeconomic review of its use in the management of asthma.
Markham A; Adkins JC
Pharmacoeconomics; 2000 Dec; 18(6):591-608. PubMed ID: 11227397
[TBL] [Abstract][Full Text] [Related]
11. Intervention Studies of Inhaled Corticosteroids Combined with Long-acting Theophylline or Long-acting β
Wang Y; Chen P; Dai A; Shang S; Kong L
Clin Ther; 2016 Dec; 38(12):2622-2627.e1. PubMed ID: 27913032
[TBL] [Abstract][Full Text] [Related]
12. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.
Kavuru M; Melamed J; Gross G; Laforce C; House K; Prillaman B; Baitinger L; Woodring A; Shah T
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1108-16. PubMed ID: 10856143
[TBL] [Abstract][Full Text] [Related]
13. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
Lyseng-Williamson KA; Plosker GL
Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
Sheth K; Borker R; Emmett A; Rickard K; Dorinsky P
Pharmacoeconomics; 2002; 20(13):909-18. PubMed ID: 12381242
[TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma.
Ortega VE; Daya M; Szefler SJ; Bleecker ER; Chinchilli VM; Phipatanakul W; Mauger D; Martinez FD; Herrera-Luis E; Pino-Yanes M; Hawkins GA; Ampleford EJ; Kunselman SJ; Cox C; Bacharier LB; Cabana MD; Cardet JC; Castro M; Denlinger LC; Eng C; Fitzpatrick AM; Holguin F; Hu D; Jackson DJ; Jarjour N; Kraft M; Krishnan JA; Lazarus SC; Lemanske RF; Lima JJ; Lugogo N; Mak A; Moore WC; Naureckas ET; Peters SP; Pongracic JA; Sajuthi SP; Seibold MA; Smith LJ; Solway J; Sorkness CA; Wenzel S; White SR; Burchard EG; Barnes K; Meyers DA; Israel E; Wechsler ME;
Lancet Child Adolesc Health; 2021 Dec; 5(12):862-872. PubMed ID: 34762840
[TBL] [Abstract][Full Text] [Related]
17. Once-daily fluticasone furoate/vilanterol versus twice-daily fluticasone propionate/salmeterol in patients with asthma well controlled on ICS/LABA.
Bernstein D; Andersen L; Forth R; Jacques L; Yates L
J Asthma; 2018 Sep; 55(9):984-993. PubMed ID: 28961020
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol and fluticasone in young children with multiple-trigger wheeze.
Mäkelä MJ; Malmberg LP; Csonka P; Klemola T; Kajosaari M; Pelkonen AS
Ann Allergy Asthma Immunol; 2012 Jul; 109(1):65-70. PubMed ID: 22727160
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study.
Briggs AH; Bousquet J; Wallace MV; Busse WW; Clark TJ; Pedersen SE; Bateman ED;
Allergy; 2006 May; 61(5):531-6. PubMed ID: 16629780
[TBL] [Abstract][Full Text] [Related]
20. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
Hagiwara M; Delea TE; Stanford RH
Allergy Asthma Proc; 2014; 35(1):54-62. PubMed ID: 24433597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
